The Effects of Pitavastatin on Nuclear Factor-Kappa B and ICAM-1 in Human Saphenous Vein Graft Endothelial Culture


Creative Commons License

Demir B., Onal B., Ozyazgan S., Demir E., Bakuy V., Akkan A. G.

CARDIOVASCULAR THERAPEUTICS, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2019
  • Doi Number: 10.1155/2019/2549432
  • Title of Journal : CARDIOVASCULAR THERAPEUTICS

Abstract

Objective. To study pitavastatin's effects on nuclear factor-kappa B (NF-B ) and adhesion molecules in human saphenous vein graft endothelial culture indicating its pleotropic properties. Materials and Method. Low-dose (0.1 M/L) and high-dose (1M/L) pitavastatin calcium were administered as a frontline therapy in human saphenous endothelial cell culture, followed by induction of inflammation by TNF- and determination of mRNA level alterations of ICAM-1 and NF-B genes of endothelial cells using the qRT-PCR method. Additionally, immunofluorescence method was used to show the expression of NF-B and ICAM-1. Finally, LDH levels were determined by the ELISA method to quantify cytotoxicity. Results. ICAM-1 mRNA expression in the low-dose pitavastatin+TNF- group was significantly higher than that in the TNF- group and significantly lower than that in the high-dose pitavastatin+TNF- group (for all comparisons, P = 0.001). The low-dose pitavastatin+TNF- group had a similar NF-B mRNA expression with TNF- and high-dose pitavastatin+TNF- groups. Conclusion. Pitavastatin increases ICAM-1 mRNA expression in saphenous vein endothelial cells. Furthermore, the effect of pitavastatin on adhesion molecules appears independent of NF-B. Novel studies are needed in this field.